Faculty
Oncology Division
John F. DiPersio, MD, PhD
Professor
Department of Medicine
Oncology Division
Bone Marrow Transplantation & Leukemia
Stem Cell Biology
Department of Pediatrics
Department of Pathology & Immunology
Clinical Interests
- Allogeneic stem cell transplantation
- Haploidentical stem cell transplantation
Research Interests
- Hematopoietic growth factor receptors
- Murine models of graft-versus-host disease and graft-versus-leukemia
- Leukemia genomics
Contact
- 314-454-8306 (tel)
- 314-454-7551 (fax)
- jdipersi@wustl.edu
- 11th Floor Mid-Campus Center (office)
- 626 Southwest Tower (lab)
- Division of Oncology
Campus Box 8007
Washington University Medical School
660 South Euclid Avenue
St. Louis, MO 63110
Biosketch
| Education | |
|---|---|
| 1973 | BA in Biology (Magna Cum Laude), Williams College, Williamstown, MA |
| 1980 | MD/PhD in Microbiology, University of Rochester, Rochester, NY |
| Post-graduate Training | |
| 1980-1981 | Intern (Straight Medicine), Parkland Memorial Hospital, UT Southwestern, Dallas, TX |
| 1981-1983 | Resident, Parkland Memorial Hospital, UT Southwestern, Dallas, TX |
| 1983-1984 | Chief Resident, Parkland Memorial Hospital, UT Southwestern, Dallas, TX |
| 1984-1987 | Fellow, Division of Hematology-Oncology, UCLA School of Medicine, Los Angeles, CA |
| Academic Positions | |
| 1987-1988 | Instructor of Medicine, Division of Hematology-Oncology, UCLA School of Medicine, Los Angeles, CA |
| 1988-1990 | Assistant Professor of Medicine, Division of Hematology-Oncology, UCLA School of Medicine, Los Angeles, CA |
| 1990-1994 | Assistant Professor of Oncology, University of Rochester School of Medicine and Dentistry, Rochester, NY |
| 1990-1994 | Director, Bone Marrow Transplant Program, Strong Memorial Hospital, Rochester, NY |
| 1990-1994 | Assistant Professor of Medicine, Hematology Unit, University of Rochester School of Medicine, Rochester, NY |
| 1994-1997 | Associate Professor of Medicine, Pediatrics and Pathology, Washington University School of Medicine, St. Louis, MO |
| 1994-2000 | Chief, Division of Bone Marrow Transplantation & Stem Cell Biology, Washington University School of Medicine, St. Louis, MO |
| 1997-present | Professor of Medicine, Pediatrics and Pathology/Immunology, Washington University School of Medicine, St. Louis, MO |
| 1997-2000 | Acting Director, Division of Medical Oncology, Washington University School of Medicine, St. Louis, MO |
| 2000-present | Deputy Director, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO |
| 2000-2006 | Director, Section of Bone Marrow Transplantation & Leukemia, Washington University School of Medicine, St. Louis, MO |
| 2000-present | Chief, Division of Oncology, Washington University School of Medicine, St. Louis, MO |
| 2006-2011 | Scientific Director, Good Manufacturing Procedure (GMP) Facility, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO |
| 2017-present | Director, Center for Gene and Cellular Immunotherapy (CGCI), Washington University School of Medicine, St. Louis, MO |
| Board Certification | |
| 1984 | American Board of Internal Medicine |
| 1987 | American Board of Internal Medicine (Medical Oncology) |
| 1988 | American Board of Internal Medicine (Hematology) |
| Other Experience & Professional Memberships | |
| 1993 | Member, Editorial Board, Journal of Experimental Hematology |
| 1995 | Member, Nominating Committee, International Society for Experimental Hematology |
| 1997 | Chairman, Nominating Committee, International Society for Experimental Hematology (ISEH) |
| 1997 | Member, Stem Cell Evaluation Committee, International Society for Hematotherapy and Graft Engineering (ISHAGE) |
| 1997 | Councilor, International Society of Experimental Hematology |
| 1998 | Member, Barnard Free Skin and Cancer Board of Directors |
| 1998 | Guest Editor, Blood Journal |
| 1999-2006 | Member, External Advisory Panel, M.D. Anderson, (MDACC) PPG-AML |
| 1999 | Deputy Director, Siteman Cancer Center, Washington University School of Medicine |
| 2000-2006 | Leukemia and Lymphoma Society of America, Career Development Award Study Section Member |
| 2000 | Chairman, NHLBI Consensus Conference on Allo Transplantation for Non-Malignant Diseases |
| 2002 | Member, Executive Committee IBMTR/ABMTR |
| 2003-2006 | Award Member, ASH Committee on Educational Affairs, Washington, DC |
| 2003-2006 | Member, Board of Directors, American Society of Biology and Marrow Transplant |
| 2004-2009 | NCI (NIH) Permanent member CONC Study Section Member |
| 2005 | Chairman, Study Section RFA HL-04-017 (NHLBI) Specialized Center for Cell Based Therapy |
| 2006 | NIH (ZRG)/CSR – Gene Therapy and Inborn Errors – Special Emphasis Review Panel |
| 2007-2012 | Co-Chair, CIBMTR Acute Leukemia Working Committee |
| 2008 | NCI P01 Special Emphasis Panel ZCA1-RPRB-J, October 2008, Bethesda MD |
| 2008 | ASH Scientific Committees on Cell and Gene Therapy and Hematopoiesis |
| 2008-2011 | Member, Scientific and Medical Research Funding; California Institute for Regenerative Medicine (CIRM) |
| 2009 | Member, Review Panel; Center Grants, National Medical Research Council, Singapore |
| 2009 | Member, ASBMT Committee on Research Priorities |
| 2010 | ASH/CRTI Faculty/Mentor |
| 2010 | Member, External Advisory Board, Cancer Therapy and Research Center, UT San Antonio |
| 2010 | Chairman, NIH NIAID ZAI1 MFH-01 P01 Special Emphasis Panel |
| 2011 | NIH (BST-M)/CSR- Special Emphasis Panel |
| 2011 | Study Section, Doris Duke Center Grants for Sickle Cell Disease |
| 2011 | Chairman, NIH/NIDDK P01 Special Emphasis Panel, Methylation and Hematopoiesis |
| 2012-2014 | Vice Chair (2012-13) and Chair (2013-14) ASH Scientific Committee on Hematopoiesis |
| 2012-present | NIH Study Section for Loan Repayment Program |
| 2012-present | EAB member, University of Michigan Cancer Center |
| 2013 | Member, NCI Provocative Questions B Study Section |
| 2013 | EAB member, Levine Cancer Institute |
| 2013-2019 | Member, Board of Scientific Councilors, National Cancer Institute (NCI) |
| 2014-2019 | Study Section Member CPRIT (Cancer Prevention Research Institute of Texas) |
| 2014 | CIRM Working Group 2.0 – Permanent Member |
| 2014-present | EAB member, University of Chicago |
| 2015 | American Cancer Society, National Board of Directors for Hope Lodges |
| 2015 | Medical Advisory Board, Gabrielle's Angel Foundation for Cancer Research |
| 2015-present | EAB member, Sylvester Comprehensive Cancer Center, University of Miami |
| 2015-2017 | Member, AACR-Aflac, Inc. Career Development Award for Pediatric Cancer Research Scientific Research Committee |
| 2016 | Chair, Data Safety Monitoring Committee (DSMC) BL-8040 and Nivolumb for the Treatment of Pancreatic Cancer |
| 2016 | Chair, DSMC Dana Farber/Boston Childrens Hospital "Use of Plerixafor for Stem Cell Mobilization in Patients with Sickle Cell Disease" |
| 2016-2019 | Member, AACR Science Policy and Government Affairs Committee (SPGAC) |
| 2017 | Review Committee Member, NIH Pioneer Award |
| 2017-2021 | Member, ASH Honorific Award and ASH Mentor Award Committee |
| 2017-2019 | Chair, for the Finneran Prize Awardee, MDACC |
| 2018 | Leukemia and Lymphoma Society New Idea Award Committee |
| 2018 | NIH/NCI Cancer Moonshot Human Tumor Atlas Study Section ZRG1 OTC-T |
| 2018-present | EAB member, DFCI Leukemia SPORE |
| 2018-present | EAB member, University of Rochester |
| 2018-present | EAB member, Weill Cornell Medicine |
| 2018-present | Member AACR Honorific Awards Committee |
| 2019 | Member Scientific Committee, 2019 Acute Leukemias SVII, Munich Germany |
| 2019-present | Member Dana Farber Cancer Institute (DFCI) External Advisory Board |
| 2019-present | Member EAB of MSKCC Leukemia SPORE |
| 2020-present | Member EAB Mt Sinai PPD in Stem Cell Transplantation |
| Honors | |
| 1973 | BA, Magna Cum Laude, Honors in Biology, Williams College |
| 1980 | Alpha Omega Alpha, University of Rochester |
| 1986 | Special Fellow, Leukemia Society of America |
| 1989 | Junior Faculty Research Award, American Cancer Society |
| 1992 | Bauman Award - Teacher of the Year, Internal Medicine, University of Rochester |
| 1996 | Elected, American Society of Clinical Investigation (ASCI) |
| 1997 | Recipient, Lewis T. and Rosalind B. Apple Chair in Oncology |
| 2001 | ISHAGE Meeting, First prize, Scientific Merit: "Control of GvHD using genetically modified T cells" |
| 2008 | "Great Teacher" Lecture NIH |
| 2010 | Recipient, Virginia E. and Samuel J. Golman Endowed Professorship in Medicine |
| 2010 | Washington University Divisions of Hematology and Oncology "Teacher of the Year" |
| 2013 | Daniel P. Schuster Distinguished Translational Investigator Award, Washington University |
| 2013 | Member, Association of American Physicians (AAP) |
| 2014 | Recipient of AACR Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Cancer Research |
| 2014 | Thomson Reuters list of "Most Influential Scientific Minds" |
| 2014 | American Society of Hematology Mentor Award for Clinical Investigation |
| 2015 | Co-founder, Magenta Therapeutics, Cambridge, MA |
| 2016 | Washington University School of Medicine 2nd Century Award |
| 2016-2017 | Vice President/President-Elect, American Society of Blood and Marrow Transplantation |
| 2017 | Leukemia and Lymphoma Society of American Legacy Award |
| 2017-2024 | R35- NCI Outstanding Investigator Award “Optimizing Allogeneic HSCT” |
| 2018-2019 | President, American Society of Blood and Marrow Transplantation |
| 2018 | Karl Blume and Gerhard Schmidt Memorial Lecture, City of Hope Cancer Center, Duarte, CA |
| 2018 | Teacher of the Year, Department of Medicine, Washington University School of Medicine |
| 2018 | Founder, WUGEN Therapeutics, St. Louis, MO |
| 2019 | Thomas Buchner Memorial Lecture, Acute Leukemias XVII, Munich, Germany |
